Furthermore, we showed that tumor necrosis factor (TNF) signaling is induced in the CP of AD patients and AD mouse models, whereas TNF receptor 1 (TNFR1) abrogation reduced brain inflammation, blood–CSF barrier impairment and AβO-induced memory impairment [14]. This evidence concerns the gene TNF and memory impairment.